The Serotonergic Transmitter System in Dementia and Affective Disorders
NCT00192998 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2007-09-27
Summary
The aim of this project is to examine the serotonergic transmitter system using functional imaging of the brain (positron emission tomography \[PET\]) to gain knowledge about early pathophysiological changes in Alzheimer's dementia and mood disorders.
Conditions
- Mood Disorders
- Alzheimer Disease
Sponsors & Collaborators
-
Rigshospitalet, Denmark
lead OTHER
Principal Investigators
-
Vibe G. Frokjaer, MD · Neurobiological Research Unit, Copenhagen University Hospital, Denmark
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2003-10-31
Countries
- Denmark
Study Locations
More Related Trials
-
PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder
NCT06452290 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Functional and Metabolic Changes in the Course of Antidepressive Treatment
NCT02099630 ·Status: COMPLETED
-
PET-MRI F-DOPA Activity in the Mesocorticolimbic System and Depressive Symptoms in the Prediction of Treatment Compatibility
NCT03026309 ·Status: UNKNOWN
-
Effect of Brain Lesion Severity on Treatment Response in Late-Life Depression
NCT00339066 ·Status: COMPLETED ·Phase: NA
-
Establish a Specific Cohort Database for Depressive Disorders
NCT05095662 ·Status: ACTIVE_NOT_RECRUITING
-
Research on the Biological Mechanism of the Efficacy of Psychotherapy for Depression Based on the fNIRS
NCT05927129 ·Status: UNKNOWN ·Phase: NA
-
Determining Changes in Brain Structure Associated With Symptoms of Late-life Depression
NCT00178087 ·Status: COMPLETED
-
Advanced MRI in Major Depression
NCT00613912 ·Status: COMPLETED
-
Brain Imaging in Depression
NCT00050700 ·Status: COMPLETED
-
Action Tendencies and Prognosis in Major Depressive Disorder
NCT04593537 ·Status: COMPLETED
-
Pathophysiology of Neurodegeneration in Late-life Depression (AV45+THK)
NCT03430869 ·Status: COMPLETED ·Phase: PHASE2
-
Research on Pathophysiology and Treatment in Depression Using Brain Derived Neurotrophic Factor and Amyloid Neuroimaging
NCT02983838 ·Status: UNKNOWN
-
The Antidepressant Advisor (Study 3): fMRI Study to Predict Treatment Response in Patients With Depression
NCT04342299 ·Status: COMPLETED
-
DPA-714 and FDG PET/MRI in Depression
NCT06565936 ·Status: RECRUITING ·Phase: NA
-
Longitudinal Study of People Presenting for First Treatment of a Mood Disorder
NCT01529905 ·Status: UNKNOWN
-
Brain Inflammation in Major Depressive Disorder Background
NCT01851356 ·Status: COMPLETED
-
Study of Morphological and Perfusion Imaging Predictors of Pejorative Outcome in Major Depressive Disorder
NCT02286024 ·Status: COMPLETED
-
fMRI Study of Treatment Changes in Major Depression
NCT01027559 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging Study of Cognitive-Behavior Therapy for Major Depressive Disorder
NCT01460212 ·Status: UNKNOWN ·Phase: PHASE4
-
Dopamine Neurotransmission in Major Depression
NCT01659814 ·Status: COMPLETED
-
Multimodal Magnetic Resonance Imaging-based Study of Electroconvulsive Efficacy Prediction in Adolescents With Depression: a Multicenter Prospective Cohort Study
NCT05889234 ·Status: RECRUITING
-
Sensory and Psychomotor Profile in Depression
NCT04031937 ·Status: COMPLETED ·Phase: NA
-
Using Neuroimaging to Investigate Major Depressive Disorder
NCT00781677 ·Status: COMPLETED
-
Evaluation of Use of Brain Activity Monitoring for Evaluation of Depression Treatment
NCT02523105 ·Status: COMPLETED ·Phase: NA
-
Characterizing Dopamine Receptor Binding in Treatment Resistant Depression
NCT03537794 ·Status: RECRUITING